Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections and Outcomes

References

• Amit S, Mishali H, Kotlovsky T, Schwaber MJ, Carmeli Y. Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors. Clin Microbiol Infect. 2015;21(1):30–34. doi:10.1016/j.cmi.2014.08.00125636924
   PubMed Web of Science ®Google Scholar
• Hsu JF, Chu SM, Huang YC, et al. Predictors of clinical and microbiological treatment failure in neonatal bloodstream infections. Clin Microbiol Infect. 2015;21(5):482 e489–417. doi:10.1016/j.cmi.2015.01.009
   Web of Science ®Google Scholar
• Jiao Y, Qin Y, Liu J, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study. Pathog Glob Health. 2015;109(2):68–74. doi:10.1179/2047773215Y.000000000425707874
   PubMed Web of Science ®Google Scholar
• Kohler PP, Volling C, Green K, Uleryk EM, Shah PS, McGeer A. Carbapenem resistance, initial antibiotic therapy, and mortality in Klebsiella pneumoniae bacteremia: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2017;38(11):1319–1328. doi:10.1017/ice.2017.19728950924
   PubMed Web of Science ®Google Scholar
• Righi E, Peri AM, Harris PN, et al. Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis. J Antimicrob Chemother. 2017;72(3):668–677. doi:10.1093/jac/dkw45927999023
   PubMed Web of Science ®Google Scholar
• Kiddee A, Assawatheptawee K, Na-Udom A, et al. Risk factors for gastrointestinal colonization and acquisition of carbapenem-resistant gram-negative bacteria among patients in intensive care units in Thailand. Antimicrob Agents Chemother. 2018;62:8. doi:10.1128/AAC.00341-18
   Web of Science ®Google Scholar
• Frere P, Hermanne JP, Debouge MH, de Mol P, Fillet G, Beguin Y. Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transplant. 2004;33(7):745–749. doi:10.1038/sj.bmt.170441414743196
   PubMed Web of Science ®Google Scholar
• Cappellano P, Viscoli C, Bruzzi P, Van Lint MT, Pereira CA, Bacigalupo A. Epidemiology and risk factors for bloodstream infections after allogeneic hematopoietic stem cell transplantation. New Microbiol. 2007;30(2):89–99.17619251
   PubMed Web of Science ®Google Scholar
• Kazlauskas E, Gegieckaite G, Eimontas J, Zelviene P, Maercker A. A brief measure of the international classification of diseases-11 adjustment disorder: investigation of psychometric properties in an adult help-seeking sample. Psychopathology. 2018;51(1):10–15. doi:10.1159/00048441529301130
   PubMed Web of Science ®Google Scholar
• Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16(1):18. doi:10.1186/s12941-017-0191-328356109
   PubMed Web of Science ®Google Scholar
• Zhang F, Li Y, Lv Y, Zheng B, Xue F. Bacterial susceptibility in bloodstream infections: results from China Antimicrobial Resistance Surveillance Trial (CARST) program, 2015–2016. J Glob Antimicrob Resist. 2019;17:276–282. doi:10.1016/j.jgar.2018.12.01630611932
   PubMed Web of Science ®Google Scholar
• Wang C, Yuan Z, Huang W, Yan L, Tang J, Liu CW. Epidemiologic analysis and control strategy of Klebsiella pneumoniae infection in intensive care units in a teaching hospital of People’s Republic of China. Infect Drug Resist. 2019;12:391–398. doi:10.2147/IDR.S18915430863122
   PubMed Web of Science ®Google Scholar
• Zhang Y, Guo LY, Song WQ, Wang Y, Dong F, Liu G. Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients. BMC Infect Dis. 2018;18(1):248. doi:10.1186/s12879-018-3160-329855274
   PubMed Web of Science ®Google Scholar
• Li M, Wang X, Wang J, et al. Infection-prevention and control interventions to reduce colonisation and infection of intensive care unit-acquired carbapenem-resistant Klebsiella pneumoniae: a 4-year quasi-experimental before-and-after study. Antimicrob Resist Infect Control. 2019;8(1):8. doi:10.1186/s13756-018-0453-730651974
   PubMed Web of Science ®Google Scholar
• Zheng X, Wang JF, Xu WL, Xu J, Hu J. Clinical and molecular characteristics, risk factors and outcomes of Carbapenem-resistant Klebsiella pneumoniae bloodstream infections in the intensive care unit. Antimicrob Resist Infect Control. 2017;6(1):102. doi:10.1186/s13756-017-0256-229026535
   PubMed Web of Science ®Google Scholar
• Katchanov J, Asar L, Klupp EM, et al. Carbapenem-resistant Gram-negative pathogens in a German university medical center: prevalence, clinical implications and the role of novel beta-lactam/beta-lactamase inhibitor combinations. PLoS ONE. 2018;13(4):e0195757. doi:10.1371/journal.pone.019575729649276
   PubMed Web of Science ®Google Scholar
• Zheng B, Dai Y, Liu Y, et al. Molecular epidemiology and risk factors of carbapenem-resistant Klebsiella pneumoniae infections in Eastern China. Front Microbiol. 2017;8:1061. doi:10.3389/fmicb.2017.0106128659886
   PubMed Web of Science ®Google Scholar
• Zhao D, Zuo Y, Wang Z, Li J. Characterize carbapenem-resistant Klebsiella pneumoniae isolates for nosocomial pneumonia and their Gram-negative bacteria neighbors in the respiratory tract. Mol Biol Rep. 2019;46(1):609–616. doi:10.1007/s11033-018-4515-y30603949
   PubMed Web of Science ®Google Scholar
• Micozzi A, Gentile G, Minotti C, et al. Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias. BMC Infect Dis. 2017;17(1):203. doi:10.1186/s12879-017-2297-928283020
   PubMed Web of Science ®Google Scholar
• Mills JP, Talati NJ, Alby K, Han JH. The epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization and infection among long-term acute care hospital residents. Infect Control Hosp Epidemiol. 2016;37(1):55–60. doi:10.1017/ice.2015.25426455382
   PubMed Web of Science ®Google Scholar
• Giacobbe DR, Del Bono V, Bruzzi P, et al. Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study. Eur J Clin Microbiol Infect Dis. 2017;36(4):663–669. doi:10.1007/s10096-016-2843-127909821
   PubMed Web of Science ®Google Scholar
• Candevir Ulu A, Kurtaran B, Inal AS, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: a serious threat in ICUs. Med Sci Monit. 2015;21:219–224. doi:10.12659/MSM.89251625595166
   PubMed Web of Science ®Google Scholar
• Wang Z, Qin RR, Huang L, Sun LY. Risk factors for carbapenem‑resistant Klebsiella pneumoniae infection and mortality of Klebsiella pneumoniae infection. Chin Med J. 2018;131:56‑62.
   Web of Science ®Google Scholar
• Tian L, Tan R, Chen Y, et al. Epidemiology of Klebsiella pneumoniae bloodstream infections in a teaching hospital: factors related to the carbapenem resistance and patient mortality. Antimicrob Resist Infect Control. 2016;5(1):48. doi:10.1186/s13756-016-0145-027891222
   PubMed Web of Science ®Google Scholar
• Liu P, Li X, Luo M, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis. Microb Drug Resist. 2018;24(2):190–198. doi:10.1089/mdr.2017.006128749714
   PubMed Web of Science ®Google Scholar
• Harada S, Aoki K, Yamamoto S, et al. Clinical and molecular characteristics of Klebsiella pneumoniae causing bloodstream infections in Japan: occurrence of hypervirulent infections in healthcare. J Clin Microbiol. 2019 JCM.01206-19. doi:10.1128/JCM.01206-19
   Web of Science ®Google Scholar
• Hu Y, Ping Y, Li L, Xu H, Yan X, Dai H. A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients. J Infect Dev Ctries. 2016;10(3):208–213. doi:10.3855/jidc.669727031451
   PubMed Web of Science ®Google Scholar